EU drugs head fears delays, health hazards as agency uprooted

LONDON (Reuters) - Access to new medicines and safety checks on existing treatments will be jeopardized if politicians pick a new home for Europe's London-based drugs regulator that is unacceptable to staff, its executive director told Reuters.